vs

Side-by-side financial comparison of RAYONIER INC (RYN) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $117.5M, roughly 1.3× RAYONIER INC). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 22.1%, a 49.1% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -81.9%).

Rayonier Inc., headquartered in Wildlight, Florida is a timberland real estate investment trust ("REIT") with assets located in softwood timber growing regions in the United States and New Zealand. Its core business segments are timber and real estate.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

RYN vs STOK — Head-to-Head

Bigger by revenue
STOK
STOK
1.3× larger
STOK
$158.6M
$117.5M
RYN
Growing faster (revenue YoY)
STOK
STOK
+3743.1% gap
STOK
3661.1%
-81.9%
RYN
Higher net margin
STOK
STOK
49.1% more per $
STOK
71.2%
22.1%
RYN

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
RYN
RYN
STOK
STOK
Revenue
$117.5M
$158.6M
Net Profit
$25.9M
$112.9M
Gross Margin
41.9%
Operating Margin
23.0%
70.2%
Net Margin
22.1%
71.2%
Revenue YoY
-81.9%
3661.1%
Net Profit YoY
-92.1%
528.0%
EPS (diluted)
$0.14
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RYN
RYN
STOK
STOK
Q4 25
$117.5M
Q3 25
$177.5M
Q2 25
$106.5M
Q1 25
$82.9M
$158.6M
Q4 24
$650.5M
$22.6M
Q3 24
$124.1M
Q2 24
$99.6M
Q1 24
$113.7M
Net Profit
RYN
RYN
STOK
STOK
Q4 25
$25.9M
Q3 25
$43.2M
Q2 25
$408.7M
Q1 25
$-3.4M
$112.9M
Q4 24
$327.1M
$-10.5M
Q3 24
$28.8M
Q2 24
$1.9M
Q1 24
$1.4M
Gross Margin
RYN
RYN
STOK
STOK
Q4 25
41.9%
Q3 25
32.9%
Q2 25
29.7%
Q1 25
21.7%
Q4 24
53.8%
Q3 24
30.4%
Q2 24
25.4%
Q1 24
24.3%
Operating Margin
RYN
RYN
STOK
STOK
Q4 25
23.0%
Q3 25
23.5%
Q2 25
13.7%
Q1 25
0.1%
70.2%
Q4 24
47.7%
-60.4%
Q3 24
15.2%
Q2 24
4.6%
Q1 24
7.6%
Net Margin
RYN
RYN
STOK
STOK
Q4 25
22.1%
Q3 25
24.3%
Q2 25
383.6%
Q1 25
-4.1%
71.2%
Q4 24
45.1%
-46.4%
Q3 24
23.2%
Q2 24
1.9%
Q1 24
1.2%
EPS (diluted)
RYN
RYN
STOK
STOK
Q4 25
$0.14
Q3 25
$0.28
Q2 25
$2.63
Q1 25
$-0.02
$1.90
Q4 24
$2.18
$-0.15
Q3 24
$0.19
Q2 24
$0.01
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RYN
RYN
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$842.9M
$274.8M
Total DebtLower is stronger
$845.3M
Stockholders' EquityBook value
$2.2B
$350.1M
Total Assets
$3.4B
$406.9M
Debt / EquityLower = less leverage
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RYN
RYN
STOK
STOK
Q4 25
$842.9M
Q3 25
$919.6M
Q2 25
$892.3M
Q1 25
$216.2M
$274.8M
Q4 24
$303.1M
$128.0M
Q3 24
$51.9M
Q2 24
$120.2M
Q1 24
$142.1M
Total Debt
RYN
RYN
STOK
STOK
Q4 25
$845.3M
Q3 25
$845.1M
Q2 25
$844.9M
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.3B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
RYN
RYN
STOK
STOK
Q4 25
$2.2B
Q3 25
$2.3B
Q2 25
$2.3B
Q1 25
$1.9B
$350.1M
Q4 24
$1.8B
$229.0M
Q3 24
$1.8B
Q2 24
$1.8B
Q1 24
$1.8B
Total Assets
RYN
RYN
STOK
STOK
Q4 25
$3.4B
Q3 25
$3.5B
Q2 25
$3.5B
Q1 25
$3.4B
$406.9M
Q4 24
$3.5B
$271.6M
Q3 24
$3.5B
Q2 24
$3.5B
Q1 24
$3.6B
Debt / Equity
RYN
RYN
STOK
STOK
Q4 25
0.38×
Q3 25
0.37×
Q2 25
0.37×
Q1 25
0.55×
Q4 24
0.59×
Q3 24
0.72×
Q2 24
0.75×
Q1 24
0.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RYN
RYN
STOK
STOK
Operating Cash FlowLast quarter
$256.7M
$131.8M
Free Cash FlowOCF − Capex
$131.7M
FCF MarginFCF / Revenue
83.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
9.91×
1.17×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RYN
RYN
STOK
STOK
Q4 25
$256.7M
Q3 25
$116.2M
Q2 25
$61.0M
Q1 25
$27.7M
$131.8M
Q4 24
$261.6M
$-23.2M
Q3 24
$66.2M
Q2 24
$55.3M
Q1 24
$52.3M
Free Cash Flow
RYN
RYN
STOK
STOK
Q4 25
Q3 25
$99.9M
Q2 25
Q1 25
$131.7M
Q4 24
$-23.2M
Q3 24
$42.2M
Q2 24
Q1 24
FCF Margin
RYN
RYN
STOK
STOK
Q4 25
Q3 25
56.3%
Q2 25
Q1 25
83.0%
Q4 24
-102.7%
Q3 24
34.0%
Q2 24
Q1 24
Capex Intensity
RYN
RYN
STOK
STOK
Q4 25
Q3 25
9.2%
Q2 25
Q1 25
0.1%
Q4 24
0.2%
Q3 24
19.3%
Q2 24
Q1 24
Cash Conversion
RYN
RYN
STOK
STOK
Q4 25
9.91×
Q3 25
2.69×
Q2 25
0.15×
Q1 25
1.17×
Q4 24
0.80×
Q3 24
2.30×
Q2 24
29.07×
Q1 24
38.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RYN
RYN

Real Estate Segment$42.3M36%
Pacific Northwest Timber Segment$19.8M17%
Stumpage Pay As Cut$19.3M16%
Improved Development$14.8M13%
Nontimber$13.2M11%
License Revenue Primarily From Hunting$5.3M4%
Land Based Solutions$2.9M2%

STOK
STOK

Segment breakdown not available.

Related Comparisons